Evaluation of skin sensitization potential of test product by Human Repeat Insult Patch Test (HRIPT). - None

The Himalaya Drug Company0 sites200 target enrollmentStarted: TBDLast updated: October 17, 2022

Trial Snapshot

No summary available.

•1.Male or female subjects 18 to 65 years of age
•2.Subjects must be generally in good health as determined from a recent medical history which is on file with the investigator.
•3.The ability of the subject to understand and sign a written informed consent form which must be obtained prior to treatment.
•4.Willingness to avoid UV exposure (sun or artificial UV) on the test sites during the course of the study.
•5.Subjects must have clear back. They should not have any infection or allergy on the tested area. They should have healthy skin on test area
•6.Subjects should be cooperative, informed of the need and duration of the examination and ready to comply with the protocol procedures
•7.Should be able to read and write in English, Hindi or any other local language.
•8.Subjects having valid proof of identity and age.
•9.Willingness to avoid excessive water contact (like swimming etc.) or activity which causes excessive sweating (like exercise, sauna, etc.) during the course of study
•10.Subjects with skin photo type III to V

•1.Pregnant women/ Nursing mothers
•2.Scars excessive terminal hair or tattoo on the studied area.
•3.Henna tattoo anywhere on the body(in case of studies involving hair dyes).
•4.Dermatological infection/pathology on the level of studied area
•5.Hypersensitivity, allergy antecedent (to any cosmetic product, raw material or hair dye)
•6.Any clinically significant systematic or cutaneous disease, which may interfere with study treatment or procedures
•7.Chronic illness which may influence the outcome of the study.
•8.Subject on any medical treatment either systemic or topical which may interfere with the performance of the study treatment (presently or in the past 1 month)
•9.Subject in an exclusion period or participating in another food, cosmetic or therapeutic trial.
•10.Subjects having mole or hair on the back which may influence the study results as per the investigator and study coordinator decision

Sponsor